Literature DB >> 17150307

Depletion of reduced glutathione enhances motor neuron degeneration in vitro and in vivo.

L Chi1, Y Ke, C Luo, D Gozal, R Liu.   

Abstract

The mechanism of selective and age-dependent motor neuron degeneration in human amyotrophic lateral sclerosis (ALS) has not been defined and the role of glutathione (GSH) in association with motor neuron death remains largely unknown. A motor neuron-like cell culture system and a transgenic mouse model were used to study the effect of cellular GSH alteration on motor neuron cell death. Exposure of NSC34 motor neuron-like cells to ethacrynic acid (EA) or l-buthionine sulfoximine (BSO) dramatically reduced the cellular GSH levels, and was accompanied by increased production of reactive oxygen species (ROS) measured by the dichlorofluorescin (DCF) fluorescent oxidation assay. In addition, GSH depletion enhanced oxidative stress markers, AP-1 transcriptional activation, c-Jun, c-Fos and heme oxygenase-1 (HO-1) expression in NSC34 cells analyzed by a luciferase reporter, Western blotting and quantitative PCR assays respectively. Furthermore, depletion of GSH decreased mitochondrial function, facilitated apoptosis inducing factor (AIF) translocation, cytochrome c release, and caspase 3 activation, and consequently led to motor neuron-like cell apoptosis. In an ALS-like transgenic mouse model overexpressing mutant G93A-Cu, Zn-superoxide dismutase (SOD1) gene, we showed that the reduction of GSH in the spinal cord and motor neuron cells is correlated with AIF translocation, caspase 3 activation, and motor neuron degeneration during ALS-like disease onset and progression. Taken together, the in vitro and in vivo data presented in the current report demonstrated that decreased GSH promotes multiple apoptotic pathways contributing, at least partially, to motor neuron degeneration in ALS.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17150307      PMCID: PMC1944995          DOI: 10.1016/j.neuroscience.2006.09.064

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  54 in total

1.  Quantifying cellular oxidative stress by dichlorofluorescein assay using microplate reader.

Authors:  H Wang; J A Joseph
Journal:  Free Radic Biol Med       Date:  1999-09       Impact factor: 7.376

2.  Schizophrenia: glutathione deficit in cerebrospinal fluid and prefrontal cortex in vivo.

Authors:  K Q Do; A H Trabesinger; M Kirsten-Krüger; C J Lauer; U Dydak; D Hell; F Holsboer; P Boesiger; M Cuénod
Journal:  Eur J Neurosci       Date:  2000-10       Impact factor: 3.386

3.  A study of glutathione S-transferase pi expression in central nervous system of subjects with amyotrophic lateral sclerosis using RNA extraction from formalin-fixed, paraffin-embedded material.

Authors:  Ewa Usarek; Beata Gajewska; Beata Kaźmierczak; Magdalena Kuźma; Dorota Dziewulska; Anna Barańczyk-Kuźma
Journal:  Neurochem Res       Date:  2005-08       Impact factor: 3.996

4.  Manganese porphyrin given at symptom onset markedly extends survival of ALS mice.

Authors:  John P Crow; Noel Y Calingasan; Junyu Chen; Julie Lynch Hill; M Flint Beal
Journal:  Ann Neurol       Date:  2005-08       Impact factor: 10.422

5.  Adaptive resistance to nitric oxide in motor neurons.

Authors:  A Bishop; J C Marquis; N R Cashman; B Demple
Journal:  Free Radic Biol Med       Date:  1999-04       Impact factor: 7.376

6.  Glutathione depletion in PC12 results in selective inhibition of mitochondrial complex I activity. Implications for Parkinson's disease.

Authors:  N Jha; O Jurma; G Lalli; Y Liu; E H Pettus; J T Greenamyre; R M Liu; H J Forman; J K Andersen
Journal:  J Biol Chem       Date:  2000-08-25       Impact factor: 5.157

7.  AIF deficiency compromises oxidative phosphorylation.

Authors:  Nicola Vahsen; Céline Candé; Jean-Jacques Brière; Paule Bénit; Nicholas Joza; Nathanael Larochette; Pier Giorgio Mastroberardino; Marie O Pequignot; Noelia Casares; Vladimir Lazar; Olivier Feraud; Najet Debili; Silke Wissing; Silvia Engelhardt; Frank Madeo; Mauro Piacentini; Josef M Penninger; Hermann Schägger; Pierre Rustin; Guido Kroemer
Journal:  EMBO J       Date:  2004-11-04       Impact factor: 11.598

Review 8.  Glutathione and signal transduction in the mammalian CNS.

Authors:  R Janáky; K Ogita; B A Pasqualotto; J S Bains; S S Oja; Y Yoneda; C A Shaw
Journal:  J Neurochem       Date:  1999-09       Impact factor: 5.372

9.  Activity and expression of glutathione S-transferase pi in patients with amyotrophic lateral sclerosis.

Authors:  Magdalena Kuźma; Zygmunt Jamrozik; Anna Barańczyk-Kuźma
Journal:  Clin Chim Acta       Date:  2005-08-18       Impact factor: 3.786

10.  Enhanced oxygen radical production in a transgenic mouse model of familial amyotrophic lateral sclerosis.

Authors:  R Liu; J S Althaus; B R Ellerbrock; D A Becker; M E Gurney
Journal:  Ann Neurol       Date:  1998-11       Impact factor: 10.422

View more
  54 in total

Review 1.  Stem cell-derived motor neurons: applications and challenges in amyotrophic lateral sclerosis.

Authors:  Jason R Thonhoff; Luis Ojeda; Ping Wu
Journal:  Curr Stem Cell Res Ther       Date:  2009-09       Impact factor: 3.828

2.  Loci affecting gamma-glutamyl transferase in adults and adolescents show age × SNP interaction and cardiometabolic disease associations.

Authors:  Rita P Middelberg; Beben Benyamin; Marleen H M de Moor; Nicole M Warrington; Scott Gordon; Anjali K Henders; Sarah E Medland; Dale R Nyholt; Eco J C de Geus; Jouke J Hottenga; Gonneke Willemsen; Lawrence J Beilin; Trevor A Mori; Margaret J Wright; Andrew C Heath; Pamela A F Madden; Dorret I Boomsma; Craig E Pennell; Grant W Montgomery; Nicholas G Martin; John B Whitfield
Journal:  Hum Mol Genet       Date:  2011-10-18       Impact factor: 6.150

3.  p53 and Cell Cycle Proteins Participate in Spinal Motor Neuron Cell Death in ALS.

Authors:  Srikanth Ranganathan; Robert Bowser
Journal:  Open Pathol J       Date:  2010-01-01

4.  MiR-34a promotes Fas-mediated cartilage endplate chondrocyte apoptosis by targeting Bcl-2.

Authors:  Huajiang Chen; Jianxi Wang; Bo Hu; Xiaodong Wu; Yu Chen; Renhu Li; Wen Yuan
Journal:  Mol Cell Biochem       Date:  2015-04-25       Impact factor: 3.396

5.  Neuroprotection against neuroblastoma cell death induced by depletion of mitochondrial glutathione.

Authors:  Vikas V Dukhande; Ivana Kawikova; Alfred L M Bothwell; James C K Lai
Journal:  Apoptosis       Date:  2013-06       Impact factor: 4.677

Review 6.  Ferroptosis, a Recent Defined Form of Critical Cell Death in Neurological Disorders.

Authors:  Jia-Rui Wu; Qing-Zhang Tuo; Peng Lei
Journal:  J Mol Neurosci       Date:  2018-08-25       Impact factor: 3.444

7.  Oxidation of Helix-3 methionines precedes the formation of PK resistant PrP.

Authors:  Tamar Canello; Kati Frid; Ronen Gabizon; Silvia Lisa; Assaf Friedler; Jackob Moskovitz; María Gasset; Ruth Gabizon
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

Review 8.  Advances in cellular models to explore the pathophysiology of amyotrophic lateral sclerosis.

Authors:  C Veyrat-Durebex; P Corcia; A Dangoumau; F Laumonnier; E Piver; P H Gordon; C R Andres; P Vourc'h; H Blasco
Journal:  Mol Neurobiol       Date:  2013-11-07       Impact factor: 5.590

9.  Characterization of detergent-insoluble proteins in ALS indicates a causal link between nitrative stress and aggregation in pathogenesis.

Authors:  Manuela Basso; Giuseppina Samengo; Giovanni Nardo; Tania Massignan; Giuseppina D'Alessandro; Silvia Tartari; Lavinia Cantoni; Marianna Marino; Cristina Cheroni; Silvia De Biasi; Maria Teresa Giordana; Michael J Strong; Alvaro G Estevez; Mario Salmona; Caterina Bendotti; Valentina Bonetto
Journal:  PLoS One       Date:  2009-12-02       Impact factor: 3.240

10.  Progranulin is expressed within motor neurons and promotes neuronal cell survival.

Authors:  Cara L Ryan; David C Baranowski; Babykumari P Chitramuthu; Suneil Malik; Zhi Li; Mingju Cao; Sandra Minotti; Heather D Durham; Denis G Kay; Christopher A Shaw; Hugh P J Bennett; Andrew Bateman
Journal:  BMC Neurosci       Date:  2009-10-27       Impact factor: 3.288

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.